Provided by Tiger Fintech (Singapore) Pte. Ltd.

AstraZeneca PLC

77.50
+1.221.60%
Post-market: 77.30-0.2000-0.26%17:11 EDT
Volume:4.87M
Turnover:377.30M
Market Cap:240.36B
PE:29.20
High:77.89
Open:76.67
Low:76.58
Close:76.28
52wk High:82.41
52wk Low:61.24
Shares:3.10B
Float Shares:3.09B
Volume Ratio:1.03
T/O Rate:0.16%
Dividend:1.57
Dividend Rate:2.02%
EPS(TTM):2.65
EPS(LYR):2.27
ROE:19.67%
ROA:8.28%
PB:5.37
PE(LYR):34.15

Loading ...

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live
·
1 hour ago

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
5 hours ago

AstraZeneca, Sophia Genetics Expand Cancer Detection Collaboration

MT Newswires Live
·
Yesterday

AstraZeneca's Koselugo Recommended for Approval in EU to Treat Neurofibromatosis Type 1

MT Newswires Live
·
Yesterday

AstraZeneca, Amgen’s Tezspire recommended for approval in EU

TIPRANKS
·
Yesterday

How the FDA Is Taking Aim at the Surreal World of TV Drug Ads -- WSJ

Dow Jones
·
Sep 21

AstraZeneca PLC ADR Falls Friday, Underperforms Market

Dow Jones
·
Sep 20

AstraZeneca PLC Stock Falls Thursday, Underperforms Market

Dow Jones
·
Sep 19

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live
·
Sep 18

Alnylam Joins Alliance for Genomic Discovery

MT Newswires Live
·
Sep 18

AstraZeneca Says FDA Approves Airsupra Label Update to Include Mild Asthma Benefits

MT Newswires Live
·
Sep 18

AstraZeneca updates Airsupra U.S. prescribing information

TIPRANKS
·
Sep 18

Brit Pop: HSBC, AZN, ARM – 3 British Stocks Saluted By Our AI Analyst

TIPRANKS
·
Sep 18

AstraZeneca (AZN.US) Files Application for Triple Asthma Therapy "Breztri" in China

Stock News
·
Sep 17

Berenberg Bank Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 17

AstraZeneca Says Phase 3 Trial of Fasenra in COPD Fails to Meet Primary Endpoint

MT Newswires Live
·
Sep 17

AstraZeneca's (AZN.US) Star Asthma Drug Fasenra Fails to Meet Primary Endpoint in Late-Stage COPD Study

Stock News
·
Sep 17

GSK Says It Will Spend $30B on U.S. Manufacturing and R&D -- Barrons.com

Dow Jones
·
Sep 17

AstraZeneca (AZN) Gets a Buy from Goldman Sachs

TIPRANKS
·
Sep 16

AstraZeneca PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
Sep 16